These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6323783)
1. [Randomized systemic chemotherapy using two or three drug combination for small cell lung cancer (SCLC)]. Eguchi K; Shimizu E; Shinkai T; Tominaga K; Saijo N; Shimabukuro Z; Shibuya M; Niitani H Gan No Rinsho; 1984 Feb; 30(2):115-21. PubMed ID: 6323783 [TBL] [Abstract][Full Text] [Related]
2. [A randomized trial of 3-drug combination chemotherapy in small cell lung cancer--CPA/ACNU/VCR vs ADR/ACNU/VCR]. Furuse K Gan To Kagaku Ryoho; 1985 Sep; 12(9):1844-9. PubMed ID: 2994577 [TBL] [Abstract][Full Text] [Related]
3. [A randomized phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin and adriamycin in combination with vincristine and ACNU in small cell lung cancer--THP-ADM, VCR, ACNU vs ADM, VCR, ACNU]. Hino M; Kobayashi K; Kurane S; Nukariya N; Yamano Y; Hasegawa K; Tsuboi E; Niitani H Gan To Kagaku Ryoho; 1989 Sep; 16(9):3143-8. PubMed ID: 2551250 [TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy for small cell carcinoma of the lung: AVN-DVC therapy]. Bando H; Yamashita T; Matunaga Y; Kinoshita S; Doi H; Ogushi F; Shimada H; Tsubura E; Morioka S; Ishimi H Gan To Kagaku Ryoho; 1984 Apr; 11(4):888-93. PubMed ID: 6326683 [TBL] [Abstract][Full Text] [Related]
5. [Randomized comparative study of CE (CDDP plus etoposide) and CE-AVN (ACNU, VCR plus procarbazine) as combined anticancer chemotherapy in small cell cancer of the lung]. Kinoshita S; Bandou H; Yamashita T; Fukuta K; Yamasaki K; Matsuura A; Shimizu E; Ogura T; Doi H; Nakamura T Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):643-8. PubMed ID: 2833178 [TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of two combination chemotherapies for the treatment of small cell carcinoma of the lung. Kutsuzawa T; Hayashi Y; Kurata T; Kobayashi R; Kondo T; Sonoda Y; Takasaki Y; Shioya S; Yamauchi T; Tamaya S Tokai J Exp Clin Med; 1984 Dec; 9(5-6):363-9. PubMed ID: 6100629 [TBL] [Abstract][Full Text] [Related]
7. [Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)]. Shibayama T; Hiyama J; Ueoka H; Tabata M; Segawa Y; Gemba K; Matsushita A; Ohnoshi T; Harada M; Andoh A Gan To Kagaku Ryoho; 1995 Nov; 22(13):1953-8. PubMed ID: 7487126 [TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy and radiotherapy in small cell carcinoma of the lung]. Yoshida S; Ogata T; Homma T; Kikuchi K; Masuda H; Matsuoka T; Sugiyama K; Noguchi Y; Yoneda S; Fukuda T Gan To Kagaku Ryoho; 1986 Jul; 13(7):2331-6. PubMed ID: 3015041 [TBL] [Abstract][Full Text] [Related]
9. [Effects of a combination chemotherapy "VEMA" consisting of vincristine, cyclophosphamide, methotrexate and ACNU in the treatment of small cell bronchogenic carcinoma]. Kojima T; Ito Y; Nakanishi F; Sugihara T; Nagata K; Kamiya O; Ohara K; Hoshino A Gan To Kagaku Ryoho; 1983 Jun; 10(6):1491-6. PubMed ID: 6307169 [TBL] [Abstract][Full Text] [Related]
10. [Multidisciplinary treatment for small cell lung cancer]. Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Takahashi K; Sasaki Y; Seki S Gan To Kagaku Ryoho; 1984 Mar; 11(3):474-9. PubMed ID: 6322700 [TBL] [Abstract][Full Text] [Related]
11. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy]. Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up. Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811 [TBL] [Abstract][Full Text] [Related]
13. [Postoperative chemotherapy of pathological stage I non-small cell carcinoma of the lung]. Kikuchi K; Ogata T Gan To Kagaku Ryoho; 1986 Jan; 13(1):24-9. PubMed ID: 3002284 [TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine(ACNU), and methotrexate (EACAM) in advanced adenocarcinoma of the lung]. Nakanishi F; Sugiishi M; Ogasawara T; Sugiura I; Kinoshita T; Ito Y; Hoshino A Gan To Kagaku Ryoho; 1985 Jun; 12(6):1339-44. PubMed ID: 3859252 [TBL] [Abstract][Full Text] [Related]
15. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S; Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326 [TBL] [Abstract][Full Text] [Related]
16. [Pilot study of multi-cyclic combination chemotherapy in small cell lung cancer]. Kurane S; Kobayashi K; Nukariya N; Morikawa T; Hino M; Sibuya M; Niitani H Gan To Kagaku Ryoho; 1991 Mar; 18(3):489-92. PubMed ID: 1848422 [No Abstract] [Full Text] [Related]
17. [The combination chemotherapy of vincristine, methotrexate, ACNU, and adriamycin for anaplastic carcinoma of the lung]. Meguro S; Kobayashi T; Chinen T; Usui N; Yamazaki H; Kobayashi A; Nagata T; Yokoyama K; Kuraishi Y; Ichiba K; Abe M Gan To Kagaku Ryoho; 1982 Jul; 9(6):1012-8. PubMed ID: 6964043 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995. Lee YC; McCrystal MR; Christmas TI N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564 [TBL] [Abstract][Full Text] [Related]
19. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy. Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer. Leighl NB; Goss GD; Lopez PG; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Pouliot JF; Rodgers A; Pond GR; Shepherd FA Lung Cancer; 2006 Jun; 52(3):327-32. PubMed ID: 16597474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]